Trial
NCT00665444
Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pittsburgh
Collaborators
Bristol-Myers Squibb
Condition
Bipolar Disorder
Intervention
Aripiprazole
Why stopped
The study was terminated by the sponser due to low study enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-22